Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Accumulated Depreciation: 2015-2022

Historic Accumulated Depreciation for Editas Medicine (EDIT) over the last 8 years, with Dec 2022 value amounting to $21.5 million.

  • Editas Medicine's Accumulated Depreciation rose 26.38% to $23.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $23.5 million, marking a year-over-year increase of 26.38%. This contributed to the annual value of $21.5 million for FY2022, which is 38.81% up from last year.
  • Editas Medicine's Accumulated Depreciation amounted to $21.5 million in FY2022, which was up 38.81% from $15.5 million recorded in FY2021.
  • In the past 5 years, Editas Medicine's Accumulated Depreciation registered a high of $21.5 million during FY2022, and its lowest value of $7.1 million during FY2018.
  • For the 3-year period, Editas Medicine's Accumulated Depreciation averaged around $16.0 million, with its median value being $15.5 million (2021).
  • Data for Editas Medicine's Accumulated Depreciation shows a peak YoY skyrocketed of 75.78% (in 2018) over the last 5 years.
  • Editas Medicine's Accumulated Depreciation (Yearly) stood at $7.1 million in 2018, then climbed by 1.00% to $7.2 million in 2019, then spiked by 54.01% to $11.1 million in 2020, then soared by 39.77% to $15.5 million in 2021, then soared by 38.81% to $21.5 million in 2022.